Skip to NavigationSkip to content

News

The UK’s Business Secretary has announced the introduction of five specialist collaborative centres across the UK which with leverage advanced...
Shares in the US-based pharma firm Clearside Biomedical plummeted on Monday after the company announced disappointing phase III trial results for...
British Health Secretary Matt Hancock has said that healthcare should focus on prevention, as he launched a long-term strategy intended to save...
Anglo-Swedish multinational AstraZeneca has agreed to sell the rights to three asthma and rhinitis drugs in a deal worth $350 million (£268 million...
Johnson & Johnson’s Janssen Biotech unit has bought the rights to Yuhan's third-generation EGFR tyrosine kinase inhibitor (TKI) ...
With news on Trump's latest attempts to tackle the US opioid and pricing crises, Brexit warnings for medicine availability and research, and features...
Despite voices of criticism, the FDA has opted to approve AcelRX’s Dsuvia (sufentanil), an opioid medication said to be five to ten times stronger...
Indian pharma firm Aurobindo Pharma Ltd has initiated a voluntary recall of 22 batches of blood pressure drug Ibesartan, due to the presence of a...
Promising phase II results suggest that MDMA-assisted psychotherapy may be an “innovative, efficacious treatment for posttraumatic stress disorder...
HIV-drug Gammora may eliminate 99% of the HIV virus within four weeks of treatment, according to the results of a Phase 1/2a clinical trial,...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches